Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.
AffiliationDepartment of Gynaecology, The Galway Clinic, Doughiska, Galway, Ireland. firstname.lastname@example.org
MeSHDrug Resistance, Neoplasm
Gestational Trophoblastic Disease
Neoplasm Recurrence, Local
MetadataShow full item record
CitationChemotherapy for resistant or recurrent gestational trophoblastic neoplasia. 2012, 12:CD008891 Cochrane Database Syst Rev
JournalCochrane database of systematic reviews (Online)
AbstractGestational trophoblastic neoplasia (GTN) is a highly curable group of pregnancy-related tumours; however, approximately 25% of GTN tumours will be resistant to, or will relapse after, initial chemotherapy. These resistant and relapsed lesions will require salvage chemotherapy with or without surgery. Various salvage regimens are used worldwide. It is unclear which regimens are the most effective and the least toxic.
Item TypeSystematic Review
- Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.
- Authors: Alazzam M, Tidy J, Osborne R, Coleman R, Hancock BW, Lawrie TA
- Issue date: 2016 Jan 13
- Combination chemotherapy for primary treatment of high-risk gestational trophoblastic tumour.
- Authors: Deng L, Zhang J, Wu T, Lawrie TA
- Issue date: 2013 Jan 31
- First-line chemotherapy in low-risk gestational trophoblastic neoplasia.
- Authors: Alazzam M, Tidy J, Hancock BW, Osborne R, Lawrie TA
- Issue date: 2012 Jul 11
- First line chemotherapy in low risk gestational trophoblastic neoplasia.
- Authors: Alazzam M, Tidy J, Hancock BW, Osborne R
- Issue date: 2009 Jan 21
- [EMA/CO regimen for chemotherapy 24 patients with ultra high-risk gestational trophoblastic neoplasia].
- Authors: Shen T, Chen LL, Qin JL, Wang XY, Cheng XD, Xie X, Lyu WG
- Issue date: 2018 Jun 25